Table A1.
Type of menopausal hormone therapy used before and after July 2002 in the Sleep in Midlife Women Study, Madison, WI, 1990–2009. N=3,899 out of 17,010 diaries
| Before July 2002 | After July 2002 | |
|---|---|---|
| Estrogen, conjugated (Cenestin, Premarin) | 464 | 186 |
| Estrogen, esterified (Estratab, Menest) | 48 | 0 |
| Estradiol (Alora, Climara, Esclim, Estrace, Estraderm, Estring, FemPatch, Gynodiol, Innofem, Vagifem, Vivel le, Vivelle-dot) | 430 | 322 |
| Estradiol & Norethindrone (Activelle, Combipatch, Femhrt) | 29 | 34 |
| Estrogen & Medroxyprogesterone (Premphase, Prempro) | 795 | 115 |
| Estrone/Estradiol/Progesterone compound | 25 | 17 |
| Medroxyprogesterone acetate (Amen, Androderm, Curretab, Cycrin, Depo-Provera, Provera) | 435 | 182 |
| Estrogen & Methyltestosterone (Estratest, Menogen) | 99 | 49 |
| Selective Estrogen-receptor modulators (Droloxifene, Raloxifene(Evista), Tamoxifen, Tiboline(Livial)) | 27 | 34 |
| Herbal and OTC preparations (Black Cohosh, Promensil, flax seed, yam extracts) | 167 | 101 |
| Estrogen (Version 1 diary onlya) | 192 | N/A |
| Progesterone (Version 1 diary onlya) | 148 | N/A |
a
Diaries used through May 1998 offered only two options to describe hormonal medications, “Estrogen” or “Progesterone.” Later versions of the diary offered more categories of medication, as well as a blank space to specify those not on the list.